|
1
|
No authors listed: Surveillance,
Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence -
SEER 9 Regs Research Data, Nov 2011 Sub (1973–2010)
<Katrina/Rita Population Adjustment> - Linked To County
Attributes - Total U.S., 1969–2010 Counties, National Cancer
Institute, DCCPS, Surveillance Research Program, Surveillance
Systems Branch, released April 2013, based on the November 2012
submission.
|
|
2
|
Miller RW, Young JL Jr and Novakovic B:
Childhood cancer. Cancer. 75:395–405. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jha P, Frölich AM, McCarville B, et al:
Unusual association of alveolar rhabdomyosarcoma with pancreatic
metastasis: emerging role of PET-CT in tumor staging. Pediatr
Radiol. 40:1380–1386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raney RB, Maurer HM, Anderson JR, et al:
The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons
from the IRS-I through IRS-IV studies as background for the current
IRS-V treatment protocols. Sarcoma. 5:9–15. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Terezakis SA and Wharam MD: Radiotherapy
for rhabdomyosarcoma: indications and outcome. Clin Oncol.
25:27–35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wolden SL, Anderson JR, Crist WM, et al:
Indications for radiotherapy and chemotherapy after complete
resection in rhabdomyosarcoma: A report from the Intergroup
Rhabdomyosarcoma Studies I to III. J Clin Oncol. 17:3468–3475.
1999.PubMed/NCBI
|
|
7
|
Regine WF, Fontanesi J, Kumar P, et al:
Local tumor control in rhabdomyosarcoma following low-dose
irradiation: comparison of group II and select group III patients.
Int J Radiat Oncol Biol Phys. 31:485–491. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schwartz CL: Long-term survivors of
childhood cancer: the late effects of therapy. Oncologist. 4:45–54.
1999.PubMed/NCBI
|
|
9
|
Stevens MC: Treatment for childhood
rhabdomyosarcoma: the cost of cure. Lancet Oncol. 6:77–84. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schuck A, Mattke AC, Schmidt B, et al:
Group II rhabdomyosarcoma and rhabdomyosarcoma-like tumors: is
radiotherapy necessary? J Clin Oncol. 22:143–149. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raney RB, Anderson JR, Barr FG, et al:
Rhabdomyosarcoma and undifferentiated sarcoma in the first two
decades of life: a selective review of intergroup rhabdomyosarcoma
study group experience and rationale for Intergroup
Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol. 23:215–220.
2001. View Article : Google Scholar
|
|
12
|
Koscielniak E, Harms D, Henze G, et al:
Results of treatment for soft tissue sarcoma in childhood and
adolescence: a final report of the German Cooperative Soft Tissue
Sarcoma Study CWS-86. J Clin Oncol. 17:3706–3719. 1999.PubMed/NCBI
|
|
13
|
Stevens MC, Rey A, Bouvet N, et al:
Treatment of nonmetastatic rhabdomyosarcoma in childhood and
adolescence: third study of the International Society of Paediatric
Oncology - SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol.
23:2618–2628. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
No authors listed: Surveillance,
Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973–2010),
National Cancer Institute, DCCPS, Surveillance Research Program,
Surveillance Systems Branch, released April 2013, based on the
November 2012 submission.
|
|
15
|
Sultan I, Qaddoumi I, Yaser S,
Rodriguez-Galindo C and Ferrari A: Comparing adult and pediatric
rhabdomyosarcoma in the surveillance, epidemiology and end results
program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol.
27:3391–3397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Harrell FE: rms: Regression Modeling
Strategies. R package version 3.6–3. http://CRAN.R-project.org/package=rms.
|
|
17
|
Austin PC: The relative ability of
different propensity score methods to balance measured covariates
between treated and untreated subjects in observational studies.
Med Decis Making. 29:661–677. 2009. View Article : Google Scholar
|
|
18
|
Austin PC, Grootendorst P and Anderson GM:
A comparison of the ability of different propensity score models to
balance measured variables between treated and untreated subjects:
a Monte Carlo study. Stat Med. 26:734–753. 2007. View Article : Google Scholar
|
|
19
|
Harrell FE: Regression Modeling
Strategies. Springer-Verlag; New York, New York: 2001, View Article : Google Scholar
|
|
20
|
R Core Team. 2013, R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna, Austria: URL http://www.R-project.org/.
|
|
21
|
Stephenson AJ, Scardino PT, Kattan MW, et
al: Predicting the outcome of salvage radiation therapy for
recurrent prostate cancer after radical prostatectomy. J Clin
Oncol. 25:2035–2041. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rouzier R, Pusztai L, Delaloge S, et al:
Nomograms to predict pathologic complete response and
metastasis-free survival after preoperative chemotherapy for breast
cancer. J Clin Oncol. 23:8331–8339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brennan MF, Kattan MW, Klimstra D and
Conlon K: Prognostic nomogram for patients undergoing resection for
adenocarcinoma of the pancreas. Ann Surg. 240:293–298. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kattan MW, Karpeh MS, Mazumdar M and
Brennan MF: Postoperative nomogram for disease-specific survival
after an R0 resection for gastric carcinoma. J Clin Oncol.
21:3647–3650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang L, Shen W and Sakamoto N:
Population-based study evaluating and predicting the probability of
death resulting from thyroid cancer and other causes among patients
with thyroid cancer. J Clin Oncol. 31:468–474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kutikov A, Egleston BL, Wong YN and Uzzo
RG: Evaluating overall survival and competing risks of death in
patients with localized renal cell carcinoma using a comprehensive
nomogram. J Clin Oncol. 28:311–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kattan MW, Leung DH and Brennan MF:
Postoperative nomogram for 12-year sarcoma-specific death. J Clin
Oncol. 20:791–796. 2002.PubMed/NCBI
|
|
28
|
Gronchi A, Miceli R, Shurell E, et al:
Outcome prediction in primary resected retroperitoneal soft tissue
sarcoma: histology-specific overall survival and disease-free
survival nomograms built on major sarcoma center data sets. J Clin
Oncol. 31:1649–1655. 2013. View Article : Google Scholar
|
|
29
|
Chisholm JC, Marandet J, Rey A, et al:
Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma:
a nomogram to better define patients who can be salvaged with
further therapy. J Clin Oncol. 29:1319–1325. 2011. View Article : Google Scholar
|
|
30
|
Wang SJ, Fuller CD, Kim JS, Sittig DF,
Thomas CR Jr and Ravdin PM: Prediction model for estimating the
survival benefit of adjuvant radiotherapy for gallbladder cancer. J
Clin Oncol. 26:2112–2117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang SJ, Lemieux A, Kalpathy-Cramer J, et
al: Nomogram for predicting the benefit of adjuvant
chemoradiotherapy for resected gallbladder cancer. J Clin Oncol.
29:4627–4632. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Albert JM, Liu DD, Shen Y, et al: Nomogram
to predict the benefit of radiation for older patients with breast
cancer treated with conservative surgery. J Clin Oncol.
30:2837–2843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Flamant F, Rodary C, Rey A, et al:
Treatment of non-metastatic rhabdomyosarcomas in childhood and
adolescence. Results of the second study of the International
Society of Paediatric Oncology: MMT84. Eur J Cancer. 34:1050–1062.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Austin PC: The performance of different
propensity score methods for estimating marginal hazard ratios.
Stat Med. 32:2837–2849. 2013. View
Article : Google Scholar : PubMed/NCBI
|
